tiprankstipranks
Trending News
More News >
RemeGen Co. Ltd. Class H (HK:9995)
:9995
Hong Kong Market

RemeGen Co. Ltd. Class H (9995) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
HK$52.00
HK$33.71B
98.47%
2 Buy
3 Hold
0 Sell
Moderate Buy
Genscript Biotech
$2.20
$4.04B
0.93
100.00%
0 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
€2.94
€3.36B
87.26%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$20.40
HK$32.88B
80.85%
0 Buy
1 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$10.70
HK$25.04B
31.99
91.76%
Shanghai Henlius Biotech, Inc. Class H
HK$47.95
HK$26.06B
29.33
154.78%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9995
RemeGen Co. Ltd. Class H
52.00
25.90
99.23%
GNNSF
Genscript Biotech
2.20
1.10
100.00%
DE:1ZLB
Zai Lab Ltd
2.94
1.33
82.61%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
20.40
9.20
82.14%
HK:2096
Simcere Pharmaceutical Group Limited
10.70
5.12
91.76%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
48.00
29.16
154.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis